Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 35 publications
The contributions of vascular comorbidities on self-reported functional issues in persons with multiple sclerosis.
Journal: Disability and rehabilitation
Published: December 10, 2024
Using Objective and Subjective Measures of Cognition to Predict Instrumental Activities of Daily Living Abilities in Multiple Sclerosis.
Journal: International journal of MS care
Published: May 20, 2024
Assessment of Efficacy and Safety of Zagotenemab: Results From PERISCOPE-ALZ, a Phase 2 Study in Early Symptomatic Alzheimer Disease.
Journal: Neurology
Published: February 22, 2024
Establishment of regression-based isometric strength reference values for the upper limb in persons with multiple sclerosis.
Journal: PM & R : the journal of injury, function, and rehabilitation
Published: October 11, 2023
Effect of Backward and Forward Walking on Lower Limb Strength, Balance, and Gait in Multiple Sclerosis: A Randomized Feasibility Trial.
Journal: International journal of MS care
Published: March 16, 2023
Safety, Tolerability, and Pharmacokinetics of Zagotenemab in Participants with Symptomatic Alzheimer's Disease: A Phase I Clinical Trial.
Journal: Journal of Alzheimer's disease reports
Published: February 13, 2023
Establishing the Test-Retest Reliability and Minimal Detectable Change of the Multiple Sclerosis Resiliency Scale.
Journal: International journal of MS care
Published: January 30, 2023
Quantification of upper limb dysfunction in the activities of the daily living in persons with multiple sclerosis.
Journal: Multiple sclerosis and related disorders
Published: December 14, 2021
Donanemab (LY3002813) Phase 1b Study in Alzheimer's Disease: Rapid and Sustained Reduction of Brain Amyloid Measured by Florbetapir F18 Imaging.
Journal: The journal of prevention of Alzheimer's disease
Published: September 29, 2021
Robust Pharmacodynamic Effect of LY3202626, a Central Nervous System Penetrant, Low Dose BACE1 Inhibitor, in Humans and Nonclinical Species.
Journal: Journal of Alzheimer's disease reports
Published: August 06, 2021
Phase II (NAVIGATE-AD study) Results of LY3202626 Effects on Patients with Mild Alzheimer's Disease Dementia.
Journal: Journal of Alzheimer's disease reports
Published: June 11, 2021
Last Updated: 09/26/2026